Aprogen KIC Inc (007460.KS)
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 1971 and is based in Seongnam-si, South Korea.
Company Info
Highlights
₩180.14B
₩138.76B
₩34.72B
₩634.00 - ₩1,794.00
₩17,000.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Aprogen KIC Inc (007460.KS) returned -12.76% year-to-date (YTD) and -42.68% over the past 12 months. Over the past 10 years, 007460.KS returned -22.07% annually, underperforming the S&P 500 benchmark at 10.85%.
007460.KS
-12.76%
-3.29%
-24.86%
-42.68%
-49.04%
-40.57%
-22.07%
^GSPC (Benchmark)
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 007460.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.64% | -7.55% | -0.55% | -3.06% | -2.73% | -12.76% | |||||||
| 2024 | -4.79% | -17.29% | 81.08% | 15.34% | -25.21% | -5.33% | 43.29% | 1.12% | -24.44% | -11.93% | -16.42% | -13.87% | -19.17% |
| 2023 | 1.22% | -1.09% | -13.21% | -14.35% | 6.89% | -6.23% | 16.80% | 29.63% | -32.77% | -30.08% | 6.92% | -1.44% | -44.06% |
| 2022 | -15.13% | 2.80% | 3.74% | 2.62% | 8.95% | 0.29% | -10.82% | -5.90% | -33.45% | 9.42% | -34.83% | -16.01% | -66.05% |
| 2021 | -11.00% | 1.37% | 12.74% | 0.72% | 2.86% | 4.41% | -8.44% | -0.97% | -7.11% | -1.32% | -21.12% | 14.24% | -17.60% |
| 2020 | -4.22% | -8.62% | -14.88% | 75.37% | -14.47% | -4.27% | -7.38% | 13.52% | -40.29% | -7.10% | 31.76% | -8.71% | -24.95% |
| 2019 | -62.37% | -12.61% | 5.26% | 41.30% | -16.12% | -14.37% | -18.61% | -3.14% | -15.74% | 20.88% | 20.91% | 2.44% | -65.06% |
| 2018 | 6.92% | -5.76% | 3.82% | -8.46% | 1.20% | -0.79% | -22.64% | 17.37% | -9.69% | -21.27% | 8.55% | -10.96% | -40.00% |
| 2017 | -0.19% | -7.46% | 16.94% | -13.43% | 3.27% | -5.73% | -14.05% | 3.17% | -10.40% | 9.50% | 384.34% | 29.35% | 396.18% |
| 2016 | -10.73% | -10.72% | 3.31% | 8.22% | -5.93% | 11.42% | -3.53% | -12.45% | 26.99% | -16.14% | 14.34% | -9.97% | -13.53% |
| 2015 | 6.30% | 43.04% | 8.11% | -10.00% | 3.33% | -6.27% | 9.75% | 18.47% | -13.68% | -3.75% | 2.65% | 4.48% | 66.03% |
| 2014 | 1.61% | -7.52% | -18.84% | 18.21% | -4.02% | -9.53% | 3.86% | -0.74% | 20.70% | -3.93% | -14.19% | -8.52% | -26.56% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 007460.KS is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Aprogen KIC Inc (007460.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Aprogen KIC Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aprogen KIC Inc was 99.60%, occurring on May 20, 2025. The portfolio has not yet recovered.
The current Aprogen KIC Inc drawdown is 99.58%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.6% | Jun 23, 2008 | 4103 | May 20, 2025 | — | — | — |
| -82.44% | Jun 25, 1997 | 849 | Dec 5, 2000 | 241 | Nov 30, 2001 | 1090 |
| -68.1% | Aug 8, 2003 | 188 | May 18, 2004 | 721 | Apr 10, 2007 | 909 |
| -63.91% | Feb 22, 2002 | 123 | Sep 30, 2002 | 205 | Jul 30, 2003 | 328 |
| -41.03% | Jan 15, 2008 | 6 | Jan 22, 2008 | 15 | Feb 15, 2008 | 21 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Aprogen KIC Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Aprogen KIC Inc, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -2,350.0%.
Valuation
The Valuation section provides an overview of how Aprogen KIC Inc is priced in the market compared to other companies in the Conglomerates industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 007460.KS compared to other companies in the Conglomerates industry. 007460.KS currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 007460.KS relative to other companies in the Conglomerates industry. Currently, 007460.KS has a P/S ratio of 1.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 007460.KS in comparison with other companies in the Conglomerates industry. Currently, 007460.KS has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |